Atlas Trials

The Role of Ischemia Modified Albumin in Patients With COVID-19

Clinical trial NCT05286268 · UNKNOWN

Trial details

NCT number
NCT05286268
Sponsor
Larissa University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19
Start date
2022-04-06
Primary completion
2022-07-01
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.